Impact of China’s Low Centralized Medicine Procurement Prices on the Cost-Effectiveness of Statins for the Primary Prevention of Atherosclerotic Cardiovascular Disease

Background: Statin medications reduce the risk of atherosclerotic cardiovascular disease (ASCVD). China’s new central government medicine procurement policy lowered statin prices by five-fold or more, which may impact the cost-effectiveness of statin therapy. Objective: To explore the impact of Chin...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Miao Wang, Jing Liu, Brandon K. Bellows, Yue Qi, Jiayi Sun, Jun Liu, Andrew E. Moran, Dong Zhao
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Ubiquity Press 2020-06-01
Saila:Global Heart
Gaiak:
cardiovascular disease
cost-effectiveness
low-density lipoprotein cholesterol
microsimulation
primary prevention
statins
Sarrera elektronikoa:https://globalheartjournal.com/articles/830
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak